INTRODUCTION
The glyoxalase system catalyses the conversion of methylglyoxal to D-lactic acid via the intermediate S-D-lactoylglutathione (Fig. 1) . It comprises two enzymes, glyoxalase I and glyoxalase II, and a catalytic amount of reduced glutathione (Carrington & Douglas, 1986; Thornalley, 1989) . Glyoxalase I (EC 4.4.1.5, lactoylglutathione lyase) catalyses the formation of S-D-lactoylglutathione from the hemithioacetal formed nonenzymically from methylglyoxal and reduced glutathione (Mannervik, 1980; Sellin et al., 1983) : 
MeCH(OH)CO-SG S-D-Lactoylgluwhione
Glyoxalase II (EC3.1.2.6, hydroxyacylglutathione hydrolase) catalyses the hydrolysis of S-D-lactoylglutathione to D-lactic acid and regenerates the reduced glutathione consumed in the glyoxalase 1-catalysed reaction (Uotila, 1989) :
MeCH(OH)CO-SG + H20 > MeCH(OH)CO2H + GSH
D-Lactic acid
The glyoxalase system is present in the cytosol of cells and cellular organelles, particularly mitochondria. It is found throughout biological life and is thought to be ubiquitous (Carrington & Douglas, 1986) . The Recent investigations have brought new developments in the involvement of the glyoxalase in cell growth and vesicle mobilization, with increasing evidence of changes in the glyoxalase system during tumour growth and diabetes mellitus, particularly relating to the development of associated clinical complications.
CELLULAR REGULATION OF THE GLYOXALASE SYSTEM
Regulation of the glyoxalase system in mammals Cell proliferation and maturation. Glyoxalase phenotypes and enzymic activities have been studied during embryogenesis. Glyoxalase phenotypes were fully formed in aborted human foetuses between 6 and 7 weeks of gestational age (Wieczorek & Dobosz, 1979) . They are among the earliest phenotypes expressed in embryogenesis. An active glyoxalase system is present through embryogenesis, tissue maturation and persists until cell death (McLellan & Thornalley, 1989 ). It appears crucial for life support. Glyoxalase activities were studied in chicken liver during embryo development and after hatching. Tissue of immature embryo had a characteristic high activity of glyoxalase I and a low activity of glyoxalase II. Mature, differentiated tissue of chick liver 15 days after hatching had a characteristic low activity of glyoxalase I and a high activity of glyoxalase II (Principato et al., 1982) .
In regenerating rat liver after partial hepatectomy, glyoxalase I activity was significantly higher than sham-operated controls at 24 and 48 h after hepatectomy, later returning to control levels, and glyoxalase II activity was significantly lower at 24 h and higher after 48 and 72 h than sham-operated control, later returning to control levels (Principato et al., 1983) . Increased glyoxalase I activity with a similar temporal response was also found in partial hepatectomized liver by Alexander & Boyer (1971) . Maximum mitosis and DNA synthesis occurs between 20 and 28 h after hepatectomy. Dixit et al. (1983) found a significant increase in DNA synthesis in partial hepatectomized liver in mice, maximizing at 24 h post-operation, with a corresponding temporal increase in the activity of glyoxalase I. Irradiation of mouse spleen induced regeneration with associated increase in DNA synthesis and concomitant increase in the activity of glyoxalase I in spleen tissue. Colchicine (1 mg/kg) inhibited radiation-induced changes in DNA synthesis and glyoxalase I activity (Sutrave & Rao, 1982) . (Thornalley, 1989; Creighton et al., 1988) .
Vesicle mobilization. Functional stimulants of polymorphonuclear leukocytes, such as serum opsonised zymosan, chemotactic peptide N-formylmethionyl-leucyl-phenylalanine ('FMLP') and the tumour-promoting phorbol diester 12-0-tetradecanoylphorbol 13-acetate ('TPA') induce secretion of cytoplasmic granules from neutrophils (Klebanoff & Clark, 1978) .
Phorbol diester induces secretion of specific granules from neutrophils, for which the receptor is thought to be protein kinase C. Stimulation of neutrophils with TPA induces an increase in the activity of glyoxalase I, a decrease in the activity of glyoxalase II (Gillespie, 1981; and a concomitant increase in cellular levels of S-D-lactoylglutathione . S-D-Lactoylglutathione (10-20 ,UM) potentiates phorbol diester-stimulated secretion of specific granules from human neutrophils (5 x 106/ml) and also influences neutrophil movement; it increases random movement and inhibits chemotactic peptide-induced chemotaxis (Thornalley, 1989) . Changes in glyoxalase activities and concomitant changes in cellular levels of S-D-lactoylglutathione may be involved in the regulation of degranulation (and possibly chemotaxis) in neutrophils.
A further example of vesicle mobilization is the secretion of histamine from basophils. Gillespie (1979) found that S-Dlactoylglutathione potentiated anti-IgE-induced secretion of histamine.
Regulation of the glyoxalase system in higher plants
The activity of glyoxalase I has been studied in several plants. In germinating pea, the activity of glyoxalase I was stimulated by indole acetic acid and inhibited by colchicine; it correlated with mitotic index (Ramaswamy et al., 1983a) . Glyoxalase I activity was also studied in Datura callus where it increased with increased growth, correlating with increase in DNA synthesis. Inhibitors of cell division, colchicine and vinblastine, arrested cell growth and decreased the activity of glyoxalase I. The glyoxalase I inhibitor squaric acid (4 mM) and high concentrations of methylglyoxal (> 10 mM) inhibited cell growth. Spermidine (1 ,UM) increased cell growth, protein and DNA synthesis, and glyoxalase I activity (Ramaswamy et al., 1983b (Ramaswamy et al., , 1984 . Callus growth from leaf discs of Brassica oleracea was inhibited by trifluoroperazine (an inhibitor of calmodulin) and lithium chloride. There was a concomitant decrease in glyoxalase I activity with decreased cell growth (Bagga et al., 1987) .
Brassica cultures may be induced to undergo differentiation by lack of hormones in basal growth medium, and dedifferentiated by addition of 1-naphthaleneacetic acid and benzyladenine. The activity of glyoxalase I decreases by approx. 50 % during differentiation (Sethi et al., 1988) . Glyoxalase II was not investigated in these studies.
Regulation of the glyoxalase system in micro-organisms Yeast glyoxalase I activity is markedly affected by nutrient conditions. There was a 15-30-fold increase in glyoxalase I activity when yeast cells were grown on a medium containing glycerol as the carbon source (Penninckx et al., 1983; or L-threonine as the nitrogen source (Murata et al., 1986b) . The increase in glyoxalase I activity may be due to increased methylglyoxal formation from the catabolism of glycerol or L-threonine. The inability of glyoxalase I-deficient mutants to respond similarly and hence to grow in these media supports this hypothesis (Penninckx et al., 1983; Murata et al., 1986b) . Glyoxalase I activity may also be induced by high concentrations of lactaldehyde and activity of glyoxalase II by hemithioacetal (Murata et al., 1986a) . TPA and mating factor induces an increase in glyoxalase I activity and a decrease in glyoxalase II activity in Saccharomyces cerevisiae Inoue et al., 1989) . Studies of S. cerevisiae CDC mutants have shown that the activity of glyoxalase I increases when yeast cells are grown on glucose as the carbon source and decreases in G1-arrested cells (Dudani et al., 1984; Murata & Kimura, 1986) .
THE GLYOXALASE SYSTEM IN DISEASE PROCESSES
The glyoxalase system in tumour growth
The activity of glyoxalase I in tumour tissues is higher, lower or about the same as the activity in corresponding non-tumour tissues. However, the activity of glyoxalase II is consistently markedly lower in tumours than in corresponding normal tissues (Jerzykowski et al., 1975b (Jerzykowski et al., , 1978 Hooper et al., 1987 Hooper et al., , 1988a Thornalley, 1989) .
Cell culture techniques have recently been used to study the modification of the human tumour cell glyoxalase system during drug-induced differentiation and serum deprivation-induced growth arrest. Hooper et al. (1987) (Hooper et al., 1988a (Thornalley & Tisdale, 1988) . Incubation of corresponding differentiated cells, neutrophils, with S-Dlactoylglutathione has no significant effect on cell viability in short-term culture (P. J. Thornalley, unpublished work) .
To dissect modifications of glyoxalase activity relating to changes in the cell cycle or to changes in differentiation status, two cell lines were studied, human transformed lymphoblastoid GM892 cells and Burkitt's lymphoma Raji( +) cells, which could be growth arrested by serum deprivation without inducing differentiation. Growth-arrested GM892 cells had a decreased activity of glyoxalase I and growth-arrested Raji cells had an increased activity of glyoxalase I relative to rapidly proliferating cells. However, the activity of glyoxalase II, which was ratelimiting in the glyoxalase system of both cell lines, increased during growth-arrest in both cell lines. This corresponded to an increase in the percentage of cells in the Go-G1 phase of the cell cycle in growth arrest. This suggests that glyoxalase activities change round the mammalian cell cycle and that the chan7ges in glyoxalase activities during drug-induced differentiation may be, in part, cell cycle-related (Hooper et al., 1988b) .
The activity of glyoxalase II in cells consistently increases during growth arrest and differentiation. Immature, rapidly proliferating tissues have a relatively low capacity to metabolize S-D-lactoylglutathione and are particularly susceptible to toxicity of this compound.
Modification of the glyoxalase system in diabetes mellitus
When human red blood cells are incubated in short-term culture with 5-50 mM-glucose in vitro, the flux of methylglyoxal metabolized to D-lactate via the glyoxalase system. increases. There is no change in glyoxalase activities but the increased flux produces increased cellular concentrations of methylglyoxal and S-D-lactoylglutathione (Thornalley, 1988) . Red blood cells have insulin-independent glucose uptake and, hence, experience periodic hyperglycaemia during diabetes mellitus, the cytoplasmic glucose concentration reflecting the rise and fall of plasma glucose levels during management of the disease. Methylglyoxal formation is probably increased by the increased production of dihydroxyacetone phosphate in the Embden-Meyerhof pathway and from fructose metabolism produced from the polyol pathway (Taylor & Agius, 1988) .
Modification of the glyoxalase system in red blood cells during experimental diabetes mellitus was investigated in streptozotocininduced diabetic mice (a model for insulin-dependent diabetes mellitus) and in obese (ob/ob) mice (a model for non-insulindependent diabetes mellitus). In both models, during the onset of diabetes, the activity of red blood cell glyoxalase I decreased by 50-60% of control values, and the activity of red blood cell glyoxalase increased by 20-30 % of control values. The whole blood concentration of methylglyoxal increased but the whole blood concentration of S-D-lactoylglutathione was not significantly changed in both diabetes models (Thornalley & Atkins, 1989) . Changes in glyoxalase activities did not correspond to those expected for a change in age distribution of red blood cells (McLellan & Thornalley, 1989) . It is clear that onset of diabetes either influences glyoxalase synthesis in red blood cell precursors or induces a post-translational modification of glyoxalase in red blood cells.
The effect of clinical diabetes mellitus on the red blood cell glyoxalase system has been assessed in patients with insulindependent and non-insulin-dependent diabetes mellitus and normal healthy controls. In both diabetic types, the concentrations of methylglyoxal and S-D-lactoylglutathione in blood samples were significantly elevated. For insulin-dependent diabetics, matched for age and duration of disease, patients with clinical complications had a significantly higher activity of glyoxalase I and a significantly lower activity of glyoxalase II than uncomplicated patients. Taken together, this suggests that patients with complications had a propensity to maintain relatively high levels of S-D-lactoylglutathione Racker (1951 Racker ( , 1954 established that the glyoxalase system metabolized methylglyoxal to D-lactate via the intermediate S-D-lactoylglutathione. This fundamentally divorced the glyoxalase system from mainstream glycolysis, known to produce L-lactate. Meantime, the biological effects of methylglyoxal, particularly relating to cytostatic activity, were being investigated.
Biological formation of methylglyoxal Undoubtedly, the greatest blight on our understanding of the presence (and function) of methylglyoxal in biological systems is the poor performance of assay techniques deployed in its measurement. A review has recently appeared on this subject (Ohmori et al., 1989) . Traditionally, methylglyoxal was determined by reaction with 2,4-dinitrophenylhydrazine, with or without chromatographic separation of the resultant dihydrazone (osazone) and spectrophotometric detection (Vogt, 1929; Fung & Grosjean, 1981) . This was used by Fodor et al. (1978) and Sato et al. (1980) to demonstrate the presence of methylglyoxal in liver and by Riddle & Lorenz (1968) to measure non-enzymic formation of methylglyoxal from glyceraldehyde. It now appears that 2,4-dinitrophenylhydrazine will form the same osazone by direct reaction with glyceraldehyde, glyceraldehyde 3-phosphate, dihydroxyacetone and dihydroxyacetone phosphate under acidic conditions (Ohmori et al., 1989) . Under the conditions used by Riddle & Lorenz (1968) , glyceraldehyde can oxidize to hydroxypyruvaldehyde which can also form an osazone (Thornalley et al., 1984; Thornalley, 1985 Thornalley, , 1986 . The reliability of estimates of the Vol. 269 formation of methylglyoxal in biological systems by the 2,4-dinitrophenylhydrazine method is questionable.
The interferences in assays of methylglyoxal have maintained a persistent controversy as to the presence and enzymic or nonenzymic formation of methylglyoxal in biological systems; this should be kept in mind when considering reviews of the older literature (e.g. Schauenstein et al., 1977) . The prospect for resolution of this problem resides in more specific and reliable assay techniques recently reported.
Assays for methylglyoxal involving derivatization with ophenylenediamine to 2-methylquinoxaline (Ohmori et al., 1987a; Thornalley, 1988) and with 4,5-dichloro-1,2-phenylenediamine to 6,7-dichloro-2-methylquinoxaline (Ohmori et al., 1987b) , have been developed. These methods appear not to be subject to the same or similar interferences as the 2,4-dinitrophenylhydrazine method (Ohmori et al., 1989) . Using these methods, biological sources of methylglyoxal have been investigated.
From recent studies, the main source of methylglyoxal in mammals appears to be glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Formation occurs by base-catalysed phosphate elimination, probably from the small amount of endiol form of glyceraldehyde 3-phosphate and dihydroxyacetone phosphate in solution (Ohmori et al., 1989) , as previously indicated by Richard (1985) .
Methylglyoxal synthase has been purified from Escherichia coli, and purified and crystallized from Proteus vulgaris (Hopper & Cooper, 1972; Tsai & Gracy, 1976 (Cooper, 1984; Penninckx et al., 1983) .
Reaction of methylglyoxal with biological molecules
Amino acids and proteins. Methylglyoxal reacts with arginine and arginyl residues in proteins (Takahashi, 1977a,b; Cheung & Fonda, 1979) . Methylglyoxal (> 10 mM) inhibits glycolytic enzymes (Leonici et al., 1989) and inhibits microtubule assembly (Miglietta & Gabriel, 1986) . Since estimates of the physiological concentration of methylglyoxal are in the range 0.1-2 ,UM (Ohmori et al., 1987b; Thornalley et al., 1988) , these effects on protein function are expected to be of little physiological significance. However, only approx. 0.1-0.4 % of glucotriose was metabolized to D-lactate in human red blood cells and promyelocytic leukaemia cells (Thornalley, 1988; Hooper et al., 1988a) which represents the maximum flux of methylglyoxal formation, with subsequent conversion to D-lactate by the glyoxalase system. So, although apparently an unavoidable consequence of the phosphotriose economy in cells, methylglyoxal formation and metabolism normally represent only a very minor fate of glucotriose.
Other sources of methylglyoxal in mammalian metabolism are: (i) from the oxidation of acetol in the metabolism of acetone (Casazza et al., 1984; Reichard et al., 1986) , and (ii) from aminoacetone formed in threonine catabolism by amine oxidase (Ray & Ray, 1983 , 1987 . However, under normal metabolic control, these appear to be minor sources of methylglyoxal (Ohmori et al., 1989) .
In prokaryotic micro-organisms, methylglyoxal is formed nonenzymically from glyceraldehyde 3-phosphate and dihydroxyacetone phosphate and also enzymically from dihydroxyacetone phosphate catalysed by methylglyoxal synthase (Cooper, 1984) .
Reaction of methylglyoxal with nucleic acids, RNA and DNA. The reactivity of methylglyoxal with nucleic acids was investigated by studying radiolabelling of polynucleotides by 14C-labelled methylglyoxal. Methylglyoxal binds to polyguanosine preferentially: relative binding to polyguanosine, adenine, cytosine and urosine was 100:7:3:0 (Shapiro et al., 1969; Krymkiewicz, 1973) . Methylglyoxal also binds reversibly to tRNA, but only little binding was observed to DNA. Binding to DNA was increased markedly by prior heat denaturation. It is a weak inhibitor of translation of natural and chemically decapped mRNA (Kozarich & Deegan, 1979; Lozano & Mezl, 1984) and induced crosslinks in DNA, as judged by the alkaline elution technique (Marinari et al., 1984) . DNA crosslinking was observed with 1.5 mM-methylglyoxal in Chinese hamster ovary cells. Crosslinks appeared to be between DNA and protein and were fully repaired after 24 h . Methylglyoxal produces an increase in sister-chromatid exchanges, which correlates to mutagenic/carcinogenic activity . Again, these effects may be of little physiological significance because they are observed at methylglyoxal concentrations 100-1000 times that found physiologically.
Biological effects of methylglyoxal
The late Albert Szent-Gyorgyi and co-workers were among the first groups to become interested in the biological effects of methylglyoxal. Cultures of E. coli were incubated with 0.2-1.0 mM-methylglyoxal. There was a reversible inhibition of = CH3COCHO Methylglyoxal cell growth with 1 mM-methylglyoxal, the most effective concentration inhibiting growth from 6 h (Egyud & Szent-Gyorgyi, 1966a) . This was associated with the inhibition of protein synthesis (Egyud & Szent-Gyorgyi, 1966b) . A more recent study shows that methylglyoxal (0.25 mM) inhibits the growth of asynchronous E. coli cells (3.7 x 106/ml) in culture but higher concentrations are required to inhibit growth for higher cell densities (Fraval & McBrien, 1980) . Szent-Gyorgyi and others suggested methylglyoxal was a physiological growth-inhibiting substance, and with its biological antagonist glyoxalase I, it controlled cell growth. Recent estimates of cellular concentrations of methylglyoxal, 0.1-2 /eM (Ohmori et al., 1987b; Thornalley et al., 1988) have suggested that this property of methylglyoxal may be of limited physiological significance. However, there was still a possibility that the growth inhibition induced by high concentrations of methylglyoxal might be pharmacologically useful in cancer chemotherapy:
Ascites tumours in albino mice were susceptible to the cytostatic effects of methylglyoxal at concentrations > 1.0 mm (Egyud & Szent-Gyorgyi, 1968) . French & Freelander (1958) had earlier reported that methylglyoxal (500 mg/kg) increased the mean lifetime of mice with ascites L1210 leukaemia by 31 % (see below).
An extensive study of the effect of methylglyoxal on tumour growth was reported by Apple & Greenberg (1967 (Jerzykowski et al., 1970) .
Given these data, it is perhaps surprising that methylglyoxal therapy is not widely used in cancer chemotherapy. The reason for this is that methylglyoxal is ineffective in vivo when administered other than peritumorally. Moreover, even for such instances, as for intraperitoneal injection for ascites tumours, doses effective for growth inhibition impair respiration and cardiac function (Jerzykowski et al., 1975a; Conroy, 1979) . Some investigators have suggested that the reason for lack of a potent antitumour effect of methylglyoxal is due to its rapid metabolism by glyoxalase and other enzyme systems. However, the toxicological assessment of methylglyoxal indicates that even if methylglyoxal levels could be elevated by a high dose or continuous infusion of methylglyoxal, or by inhibition of glyoxalase I, the corresponding impairment of cardiac and respiratory function would prevent exploitation of the antitumour effects (Jerzykowski et al., 1975a) .
The recognition of the toxicity of methylglyoxal has prompted the proposal that the function of the glyoxalase system is the detoxification of methylglyoxal. Mannervik and co-workers suggested the function of the glyoxalase system was to protect mammals from methylglyoxal produced by intestinal microflora (Mannervik, 1980) . Indeed, there is experimental evidence to support a detoxification function: an E. coli clone with a 200-fold increase in activity of glyoxalase I was resistant to the toxicity of a challenge of 5 mM-methylglyoxal (Rhee et al., 1987) , and a Saccharomyces cerevisiae mutant deficient in glyoxalase I activity was particularly sensitive to methylglyoxal toxicity (Penninckx et al., 1983 ). Yet, in these examples, the argument for the glyoxalase system functioning as a detoxification system is clear Vol. 269 because the threat to cell survival is clear under these experimental conditions. In normal, physiologically functioning cell systems, the concentration of methylglyoxal is low (0.1-2,m; Ohmori et al., 1987b; Thornalley et al., 1988) and the rate of formation of methylglyoxal is low (the flux through the glyoxalase system amounts for only 0.08-0.40 % of glucotriose metabolized; Thornalley, 1988; Hooper et al., 1988 (Han et al., 1977; Sellin et al., 1983) . Mammalian glyoxalase I has an isoelectric point of 4.7-4.8, an acidic protein, whereas the yeast enzyme has an isoelectric point of 7.0 (Marmstal & Mannervik, 1978; . Antibodies raised against mammalian glyoxalase I will crossreact with antigen from other mammalian species, but not with antigen from yeast (Larsen et al., 1985) .
Substrate specfficity. The physiological cofactor for glyoxalase I is reduced glutathione (y-L-glutamyl-L-Cysteinylglycine). LCysteine, oxidized glutathione, L-cysteinylglycine and y-Lglutamylcysteine are inactive as cofactors (Carnegie, 1963; Wieland et al., 1956a; Behrens, 1941) .
Glyoxalase I has a broad substrate specificity for aoxoaldehydes. Substrates include methylglyoxal, hydroxypyruvaldehyde, hydroxypyruvaldehyde phosphate, glyoxal, phenylglyoxal and many other alkyl-and aryl-glyoxals (Reeves & Ajl, 1965; Weaver & Lardy, 1961; Vander Jagt et al., 1975;  Carrington & Douglas, 1988) . The Km and Vmax. decrease as the hydrophobicity of the side chain increases.
Kinetics. The molecular species which binds to the active site of glyoxalase I is the hemithioacetal formed non-enzymically from a-oxoaldehyde and reduced glutathione (Marmstal & Mannervik, 1981 Patthy (1978) .
Glyoxalase I catalyses the isomerization of the hemithioacetal to S-D-lactoylglutathione. The rate approximates to MichaelisMenten kinetics over a restricted substrate concentration range below saturation conditions. The initial velocity-saturation behaviour is non-Michaelian. With purified enzymes, Mannervik found evidence for competitive inhibition by glutathione at high concentration (Marmstal & Mannervik, 1981) . The Michaelis constant, K,, values for the hemithioacetal with purified enzyme are given in Table 1 . The molecular activity (turnover number), kcat, is (59-71) x 103 min-' for mammalian enzymes and 35400 min-' for the yeast enzyme; the molecular activities per subunit for the enzymes are similar. The values of kcat/Km are 107-108 M-1 -1, which is close to the theoretical diffusion limit maximum, indicating that glyoxalase I is a very efficient enzyme .
Studies of the active site. Chemical modification studies of mammalian glyoxalase I suggest there is a tyrosyl residue, a 1981; Mannervik et al., 1975; Baskaran & Balasubramanian, 1987) . In contrast, yeast glyoxalase I has a cysteinyl residue, an arginyl residue and a tyrosyl residue in the active site (Ekwall & Mannervik, 1970; Schasteen & Reed, 1983; Carrington & Douglas, 1985) .
Catalytic mechanism of glyoxalase I. The mechanism proposed for the glyoxalase I reaction consistent with experimental evidence involves a shielded-proton transfer from C-1 to C-2 of the hemithioacetal, bound in the active site, to form an ene-diolate intermediate and rapid ketonization to the thioester product (Fig. 3) .
The identity of the base, B, which deprotonizes the hemithioacetal, is uncertain. It has been suggested that a histidine residue fulfils this role as a general base catalyst. The ability of imidazole to promote the analogous non-enzymic reaction suggests this is possible, yet, the evidence for a histidine residue in the active site of glyoxalase I is presently not widely accepted (Hall et al., 1978; Douglas, 1987) .
Genetics and polymorphism. Human glyoxalase I was found to exhibit genetic polymorphism originally in red blood cells (Kompf et al., 1975a) . There are three phenotypes, GLO 1-1, GLO 2-1 and GLO 2-2, representing the homozygous and heterozygous expression of a two-allelic gene, GLO1 and GLO2 at an autosomal locus. GLO 1-1 is electrophoretically 'slow' and GLO 2-2 is electrophoretically 'fast' (Kompf et al., 1975b References: , Aronsson & Mannervik (1977) , Han et al. (1976) , , Oray & Norton (1980), Baskaran & Balasubramanian (1987) , Rhee et al. (1986) , Douglas et al. (1986 (Sellin et al., 1983.) human tissues in each of 49 autopsies (Stohlmacher & Haferland, 1980) .
The GLO' and GLO2 alleles are inherited autosomally in a two-allele codominant manner and characteristic phenotypic expressions are present in all tissues. The GLO locus has been assigned to chromosome 6 (Bender & Grzeschik, 1976 ), close to the major histocompatibility complex (Kompf et al., 1976) . GLO is between the centromere and HLA-DR (Bakker et al., 1979; Leach et al., 1986) ; the meiotic distance between GLO and HLA-DR loci is 6 cM (Fig. 4) . It is not clear why major histocompatibility antigens and GLO loci have remained linked through evolution in spite of a relatively large recombination distance. - The GLO genetic locus has been linked to insulin-dependent diabetes mellitus. A study of GLO gene frequencies has shown that there is a significant excess of glyoxalase homozygote GLO 1-1 and a deficiency of types GLO 2-1 and GLO 2-2 in insulindependent diabetic patients relative to controls (McCann et al., 1981) . A GLO1 allele frequency in insulin-dependent diabetes higher than in non-diabetic patients was reported by Cambdonde Mouzon et al. (1982) . Other studies have not found changes in GLO 1-1 phenotype or GLO' allele frequency in insulindependent diabetic patients (Tokanaga et al., 1982; Kirk et al., 1985) . For non-insulin-dependent diabetic patients, Kirk et al. (1979) found an excess of GLO 2-2 phenotype and a deficiency of GLO 1-2 phenotype whereas other surveys (Kirk et al., 1985; McCann et al., 1981) produced no significant difference. However, more interestingly, insulin-dependent diabetic patients without clinical complications had a significant excess of the homozygote GLO 1-1 whereas patients with complications did not (McCann et al., 1981) . Our experimental results have suggested that there is a correlation between glyoxalase activities and the development of clinical complications in insulinVol. 269 C Chr-6 q dependent diabetic patients. The work of McCann et al. (1981) suggests there may be a genetic trait for resistance to diabetic complications. These studies hold great promise for the future.
Inhibition of glyoxalase I. Inhibitors of glyoxalase I have been designed from analogues of the hemithioacetal substrate based on glutathione derivatives and analogues of the enediol moiety of the putative transition state. Other inhibitors have been discovered by serendipity (Jordan et al., 1983; Douglas & Shinkai, 1985) .
Molecular cloning of glyoxalase I. The genes for glyoxalase I in S. cerevisiae and in Pseudomonas putida have been cloned and their phenotypic characteristics determined.
The gene for yeast glyoxalase I was cloned onto the YEp 13 plasmid. The hybrid plasmid, pY617, tranformed haploid S. cerevisiae cells. Transformed cells had 4-5-fold increased glyoxalase I activity, resistance to methylglyoxal toxicity and increased cell size relative to control transformed cells with YEpl3 .
The gene for glyoxalase I in P. putida was cloned onto the vector plasmid pBR322. The resulting plasmid, pGI423, transformed E. coli cells. Transformed cells had a 150-fold increase in glyoxalase I activity and resistance to methylglyoxal toxicity (Rhee et al., 1987) .
The nucleotide sequence of the glyoxalase I gene from P. putida has been determined and the amino acid sequence deduced. The molecular mass of the enzyme from the nucleotide sequence is 18442 (20000 estimated from the purified enzyme). The Nterminal amino acid sequence determined with the purified enzyme is Ser-Leu-Asp-Asn, whereas the nucleotide sequence indicates Met-Ser-Leu-Asp-Asn. This suggests some post-translational processing of the N-terminal methionine residue (Rhee et al., 1988) .
Glyoxalase II
Distribution and molecular characteristics. Enzymic activity of glyoxalase II is found throughout biological life. It is found in cell cytosols and in mitochondria but its presence in other organelles is less well-established (Jerzykowski et al., 1978; Talesa et al., 1988; Uotila, 1989) .
The molecular mass of the enzyme is in the range 18-29 kDa. The enzyme is a monomer. Glyoxalase II is a basic protein with pI values of 7.4-9.7 depending on the source. In rat liver, 10-15 % of total glyoxalase II activity is in the mitochondria. The cytosolic enzyme consists of two forms of molecular mass 17 and 29 kDa, and pI values between 7.4 and 8.1 (Principato et al., 1987b; Talesa et al., 1988) (Table 2) .
Substrate specificity. Glyoxalase II can catalyse the hydrolysis of a wide range of S-D-hydroxyacylglutathione derivatives. With S-lactoyl [CH3CH(OH)CO-], S-glycolyl (HOCH2CO-), S-mandelyl [PhCH(OH)CO-], S-glyceroyl [HOCH2CH(OH)CO-] and S-acetoacetyl (CH3COCH2CO-) glutathiones, the relative kinetic activity with glyoxalase II is maintained during purification. Pure glyoxalase II is inactive with thioesters of CoA and thioglycollate, indicating a high specificity for the glutathione moiety (Uotila, 1973 This has suggested that glyoxalase II is a very efficient catalyst for hydrolysis of S-D-lactoylglutathione .
Structure of the active site and catalytic mechanism. Chemical modification studies of glyoxalase II have indicated the presence of arginine, histidine and lysine residues in the active site of glyoxalase II (Ball & Vander Jagt, 1981; Principato et al., 1985; Uotila, 1973) . The mechanism proposed for the glyoxalase IIcatalysed reaction involves an active site histidine residue. (1984, 1985, 1987a,b) , Talesa et al. (1988 Talesa et al. ( , 1989 , Uotila (1973 Uotila ( , 1979 (Ball & Vander Jagt, 1981) . This is in keeping with the nucleophilicity of the imidazole group and the reactivity of N-acylimidazoles towards hydrolysis (Hall et al., 1978; Jencks & Carriuolo, 1959) (Fig. 5) . The difference in the kinetics of hydrolysis of S-D-and S-Llactoylglutathione (Wieland et al., 1956b) suggests some interactions between the a-hydroxyl group of the lactoyl moiety with the enzyme active site.
Genetics and polymorphism. The gene for glyoxalase II in humans is on chromosome 16 (Honey & Shows, 1981) . There is usually only one phenotype expressed, although a rare second form (frequency 0.016) was found in a Micronesian population (Board, 1980) . Glyoxalase II polymorphism deserves further investigation, however, since one of only two published surveys (Charlesworth, 1972) Al-Timari & Douglas, 1986 lactoylglutathione to S-D-lactoylcysteinylglycine which rearranges to N-lactoylcysteinylglycine (Tate, 1975) S-D-Lactoylglutathione induces some extraordinary and unexpected biological responses: it potentiates the GTP-promoted assembly of microtubules from porcine brain microtubular protein over the physiological concentration range (Hooper, 1988) and influences neutrophil movement and stimulus-induced secretion of granules (Thornalley, 1989) . Moreover, addition of S-D-lactoylglutathione to HL60 leukaemia cells in culture induces growth arrest and toxicity (Thornalley & Tisdale, 1988) . We have also found increased S-D-lactoylglutathione formation during OH) hyperglycaemia associated with diabetes mellitus and the development ofclinical complications was correlated to a propensity to maintain high cellular levels of S-D-lactoylglutathione . Kimura and co-workers have recently + GSH found functional regulation of S-D-lactoylglutathione in yeast cells Inoue et al., 1989) . Research is now in progress studying the effects of S-D-lactoylglutathione and analogues, and pharmacological agents which influence S-D-lactoylglutathione concentration to define the biological fate and function of S-D-lactoylglutathione and to put this to therapeutic benefit.
THE ENERGETIC ARGUMENT FOR THE EXISTENCE OF A GLYOXALASE SYSTEM IN BIOLOGICAL LIFE AND THE REACTIVITY OF S-D-

LACTOYLGLUTATHIONE
The need for the glyoxalase system in biological metabolism probably stems from the chemistry of dihydroxyacetone phosphate and the presence of reduced glutathione in cell systems. The chemical and biochemical properties of dihydroxyacetone phosphate provide for non-enzymic and enzymic formation of methylglyoxal, and the presence of reduced glutathione affords the formation of hemithioacetal (Fig. 2) . Since the equilibrium for hemithioacetal formation lies strongly over to the product, reduced glutathione would be increasingly withdrawn from other cellular functions for hemithioacetal formation if there was no glyoxalase system. The hemithioacetal may be excreted but at the loss of cellular glutathione. Hence, evolutionary pressures have preserved the glyoxalase system. The necessity for a cellular glyoxalase system is implied by the energetics of methylglyoxal and hemithioacetal formation .
S-D-Lactoylglutathione is now the focus of future glyoxalase research. Little is known of its reactivity with proteins, but from the chemical model studies of the thioesters with imidazole (Jencks & Carriuolo, 1959; Hall et al., 1978) , it is expected that reactive histidyl residues in proteins proximate to a suitable recognition site for the glutathione moiety will describe and define the locus of S-D-lactoylglutathione biological reactivity. Szent-Gyorgyi (1977) 
